anmelden
NASDAQ 100
29.060,29
PKT
-16,93
PKT
-0,06
%
Indikation, realtime*
29.077,22
PKT
-379,75
PKT
-1,29
%
Offiziell
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NASDAQ 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 25.02.11 | Vertex Pharmaceuticals hold | ThinkEquity Partners LLC | |
| 25.02.11 | Regeneron Pharmaceuticals outperform | RBC Capital Markets | |
| 24.02.11 | Vertex Pharmaceuticals hold | ThinkEquity Partners LLC | |
| 24.02.11 | Gilead Sciences outperform | RBC Capital Markets | |
| 24.02.11 | Booking outperform | RBC Capital Markets | |
| 24.02.11 | Booking buy | Caris & Company, Inc. | |
| 24.02.11 | Linde add | WestLB AG | |
| 25.02.11 | Vertex Pharmaceuticals overweight | Piper Jaffray & Co. | |
| 01.03.11 | Booking buy | Goldman Sachs Group Inc. | |
| 25.02.11 | AMD (Advanced Micro Devices) buy | Nomura | |
| 24.02.11 | Autodesk overweight | Barclays Capital | |
| 24.02.11 | Apple overweight | Barclays Capital | |
| 25.02.11 | Vertex Pharmaceuticals buy | Goldman Sachs Group Inc. | |
| 23.02.11 | Autodesk neutral | Credit Suisse Group | |
| 23.02.11 | Amazon buy | UBS AG | |
| 23.02.11 | Western Digital buy | Stifel, Nicolaus & Co., Inc. | |
| 23.02.11 | Regeneron Pharmaceuticals hold | Stifel, Nicolaus & Co., Inc. | |
| 23.02.11 | Walmart halten | Independent Research GmbH | |
| 24.02.11 | Walmart overweight | Barclays Capital | |
| 25.02.11 | Applied Materials overweight | Piper Jaffray & Co. | |
| 25.02.11 | Walmart buy | Citigroup Corp. | |
| 23.02.11 | Applied Materials overweight | Barclays Capital | |
| 23.02.11 | QUALCOMM outperform | Sanford C. Bernstein and Co., Inc. | |
| 23.02.11 | Netflix overweight | Piper Jaffray & Co. | |
| 23.02.11 | Applied Materials neutral | Credit Suisse Group | |
| 24.02.11 | QUALCOMM overweight | Piper Jaffray & Co. | |
| 23.02.11 | Apple overweight | Piper Jaffray & Co. | |
| 25.02.11 | Amazon buy | Citigroup Corp. | |
| 23.02.11 | Netflix outperform | Oppenheimer & Co. Inc. | |
| 21.02.11 | Intuit overweight | Barclays Capital | |
| 21.02.11 | Intuit buy | Citigroup Corp. | |
| 18.02.11 | Intuit outperform | Oppenheimer & Co. Inc. | |
| 18.02.11 | Intuit neutral | Credit Suisse Group | |
| 18.02.11 | Intel outperform | Credit Suisse Group | |
| 18.02.11 | PepsiCo neutral | Credit Suisse Group | |
| 18.02.11 | Teradyne overweight | Barclays Capital | |
| 18.02.11 | Amgen overweight | Barclays Capital | |
| 18.02.11 | Gilead Sciences kaufen | Der Aktionär | |
| 18.02.11 | Intuit buy | Citigroup Corp. | |
| 18.02.11 | NVIDIA buy | Needham & Company, LLC |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.
